Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center.

Autor: Muldoon, Megan¹ (AUTHOR), Beck, Mollie¹ (AUTHOR), Sebree, Nichlas^1,2 (AUTHOR), Yoder, Robin¹ (AUTHOR), Ritter, Stacey¹ (AUTHOR), Allen, Josiah D.¹ (AUTHOR), Alqahtani, Zuhair² (AUTHOR), Grund, Jaime¹ (AUTHOR), Philips, Brooke¹ (AUTHOR), Hesse, Kristina¹ (AUTHOR), El Rouby, Nihal^1,2 (AUTHOR) elroubnl@ucmail.uc.edu

Publikováno v: CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Reply to "A call for reporting of tumor-specific outcomes in studies of DPYD genotyping".

Autor: El Rouby N; St Elizabeth Healthcare, Edgewood, Kentucky, USA.; Department of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Allen JD; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Muldoon M; Swedish Hospital, Part of Endeavor Health, Chicago, Illinois, USA., Beck M; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Hesse K; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Sebree N; University of Cincinnati Medical Center, Cincinnati, Ohio, USA., Yoder R; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Ritter S; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Alqahtani Z; Department of Pharmacy Practice and Administrative Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio, USA., Grund J; St Elizabeth Healthcare, Edgewood, Kentucky, USA., Holbrook BP; St Elizabeth Healthcare, Edgewood, Kentucky, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70008.